Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
107 participants
OBSERVATIONAL
2020-03-01
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Health Belief Model Interventions on Preventive Beliefs in Secondhand Smoke Exposure
NCT06683144
The Effect of Education Based on Health Belief Model on Smoking Behaviors of Visually Impaired Individuals
NCT05910203
Comparison of the Health Literacy of Our Patients Who Quit Smoking and Who Cannot Quit Smoking
NCT04896554
The Effect of an Anti-Smoking Mobile Application on Self-Efficacy, Decision Making and Breath Carbon Monoxide Levels
NCT06492772
The Effect of BSE Training on Breast Cancer Knowledge Level and Health Beliefs
NCT06886594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study included 53 right eyes of 53 subjects (study group), who used ST and 54 right eyes of 54 healthy subjects without ST (control group). Following a full ophthalmological examination, baseline measurements were taken with optical biometry and these measurements were repeated at 5, 30 and 60 mins after using ST.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smokeless tobacco
Individuals using smokeless tobacco
optical biometry measurement
The measurements of the individuals using smokeless tobacco and those who do not were taken by optical biometry.
No smokeless tobacco
Individuals who do not use smokeless tobacco
optical biometry measurement
The measurements of the individuals using smokeless tobacco and those who do not were taken by optical biometry.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
optical biometry measurement
The measurements of the individuals using smokeless tobacco and those who do not were taken by optical biometry.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A subject who was not using ST
Exclusion Criteria
* Systemic chronic disease (diabetes, hypertension, neurological, etc.)
* Ocular trauma
* Ocular surgery
* Glaucoma
* Optic disc abnormalities
* Congenital anomaly
26 Years
49 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdullah Beyoğlu
Assist of Prof
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdullah Beyoğlu
Role: STUDY_CHAIR
Kahramanmaras Sutcu Imam University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abdullah Beyoğlu
Kahramanmaraş, None Selected, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
decision no: 285 dated:24-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.